Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912781878> ?p ?o ?g. }
- W2912781878 abstract "Background: Pimobendan has been shown to impart a significant survival benefit in cardiomyopathic cats who receive it as part of heart failure therapy. However, use of pimobendan remains controversial in cats with hypertrophic cardiomyopathy (HCM) due to lack of pharmacodynamic data for pimobendan in cats with HCM and due to theoretical concerns for exacerbating left ventricular outflow tract obstructions. Hypothesis/Objectives: Our objective was to investigate the cardiac effects of pimobendan in cats with HCM. We hypothesized that pimobendan would not exacerbate left ventricular outflow tract obstructions and that it would improve echocardiographic measures of diastolic function. Animals: Thirteen purpose-bred cats were studied from a research colony with naturally-occurring HCM due to a variant in myosin binding protein C. Methods: Cats underwent two examinations 24 h apart with complete standard echocardiography. On their first day of evaluation, they were randomized to receive oral placebo or 1.25 mg pimobendan 1 h prior to exam. On their second examination, they were crossed over and received the remaining treatment. Investigators were blinded to all treatments. Results: The pimobendan group had a significant increase in left atrial fractional shortening (pimobendan group 41.7% ± 5.9; placebo group 36.1% ± 6.0; p = 0.04). There was no significant difference in left ventricular outflow tract (LVOT) velocities between the groups (pimobendan group 2.8 m/s ± 0.8; placebo group 2.6 m/s ± 1.0). There were no significant differences between the number of cats with LVOT obstructions between groups (12 in pimobendan group; 11 in placebo group; p = 1.00). There were no detectable differences in any systolic measures, including left ventricular fractional shortening, mitral annular plane systolic excursion, and tricuspid annular plane systolic excursion. Doppler-based diastolic function assessment was precluded by persistent tachycardia. Conclusions: Improved left atrial function in the pimobendan group could explain some of the reported survival benefit for HCM cats in CHF. Pimobendan did not exacerbate LVOT obstructions and thus may not be contraindicated in HCM cats with LVOT obstructions. Future studies are needed to better characterize other physiologic effects, particularly regarding diastolic function assessment, and to better assess safety of pimobendan over a longer time-course." @default.
- W2912781878 created "2019-02-21" @default.
- W2912781878 creator A5004007930 @default.
- W2912781878 creator A5012402602 @default.
- W2912781878 creator A5015804841 @default.
- W2912781878 creator A5059072719 @default.
- W2912781878 creator A5079027517 @default.
- W2912781878 creator A5081307424 @default.
- W2912781878 date "2019-02-04" @default.
- W2912781878 modified "2023-09-25" @default.
- W2912781878 title "Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study" @default.
- W2912781878 cites W1834130069 @default.
- W2912781878 cites W1969400014 @default.
- W2912781878 cites W1973407577 @default.
- W2912781878 cites W1976853607 @default.
- W2912781878 cites W1988649103 @default.
- W2912781878 cites W2008603872 @default.
- W2912781878 cites W2009920938 @default.
- W2912781878 cites W2020803445 @default.
- W2912781878 cites W2039662339 @default.
- W2912781878 cites W2068882703 @default.
- W2912781878 cites W2079963284 @default.
- W2912781878 cites W2083073839 @default.
- W2912781878 cites W2093976074 @default.
- W2912781878 cites W2094448980 @default.
- W2912781878 cites W2134055434 @default.
- W2912781878 cites W2134992907 @default.
- W2912781878 cites W2136038989 @default.
- W2912781878 cites W2145068735 @default.
- W2912781878 cites W2251190636 @default.
- W2912781878 cites W2251226408 @default.
- W2912781878 cites W2289867517 @default.
- W2912781878 cites W2300271655 @default.
- W2912781878 cites W2301927677 @default.
- W2912781878 cites W2508412301 @default.
- W2912781878 cites W2525681105 @default.
- W2912781878 cites W2741463158 @default.
- W2912781878 cites W2768621658 @default.
- W2912781878 cites W2773643274 @default.
- W2912781878 cites W2799694745 @default.
- W2912781878 cites W4246106509 @default.
- W2912781878 doi "https://doi.org/10.3389/fvets.2019.00015" @default.
- W2912781878 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6369151" @default.
- W2912781878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30778391" @default.
- W2912781878 hasPublicationYear "2019" @default.
- W2912781878 type Work @default.
- W2912781878 sameAs 2912781878 @default.
- W2912781878 citedByCount "16" @default.
- W2912781878 countsByYear W29127818782020 @default.
- W2912781878 countsByYear W29127818782021 @default.
- W2912781878 countsByYear W29127818782022 @default.
- W2912781878 countsByYear W29127818782023 @default.
- W2912781878 crossrefType "journal-article" @default.
- W2912781878 hasAuthorship W2912781878A5004007930 @default.
- W2912781878 hasAuthorship W2912781878A5012402602 @default.
- W2912781878 hasAuthorship W2912781878A5015804841 @default.
- W2912781878 hasAuthorship W2912781878A5059072719 @default.
- W2912781878 hasAuthorship W2912781878A5079027517 @default.
- W2912781878 hasAuthorship W2912781878A5081307424 @default.
- W2912781878 hasBestOaLocation W29127818781 @default.
- W2912781878 hasConcept C126322002 @default.
- W2912781878 hasConcept C142724271 @default.
- W2912781878 hasConcept C164705383 @default.
- W2912781878 hasConcept C204787440 @default.
- W2912781878 hasConcept C27081682 @default.
- W2912781878 hasConcept C2777361368 @default.
- W2912781878 hasConcept C2778198053 @default.
- W2912781878 hasConcept C2778797674 @default.
- W2912781878 hasConcept C2779904517 @default.
- W2912781878 hasConcept C2780185194 @default.
- W2912781878 hasConcept C2780225090 @default.
- W2912781878 hasConcept C71924100 @default.
- W2912781878 hasConcept C87813604 @default.
- W2912781878 hasConceptScore W2912781878C126322002 @default.
- W2912781878 hasConceptScore W2912781878C142724271 @default.
- W2912781878 hasConceptScore W2912781878C164705383 @default.
- W2912781878 hasConceptScore W2912781878C204787440 @default.
- W2912781878 hasConceptScore W2912781878C27081682 @default.
- W2912781878 hasConceptScore W2912781878C2777361368 @default.
- W2912781878 hasConceptScore W2912781878C2778198053 @default.
- W2912781878 hasConceptScore W2912781878C2778797674 @default.
- W2912781878 hasConceptScore W2912781878C2779904517 @default.
- W2912781878 hasConceptScore W2912781878C2780185194 @default.
- W2912781878 hasConceptScore W2912781878C2780225090 @default.
- W2912781878 hasConceptScore W2912781878C71924100 @default.
- W2912781878 hasConceptScore W2912781878C87813604 @default.
- W2912781878 hasLocation W29127818781 @default.
- W2912781878 hasLocation W29127818782 @default.
- W2912781878 hasLocation W29127818783 @default.
- W2912781878 hasLocation W29127818784 @default.
- W2912781878 hasLocation W29127818785 @default.
- W2912781878 hasLocation W29127818786 @default.
- W2912781878 hasOpenAccess W2912781878 @default.
- W2912781878 hasPrimaryLocation W29127818781 @default.
- W2912781878 hasRelatedWork W1594406318 @default.
- W2912781878 hasRelatedWork W1979265875 @default.
- W2912781878 hasRelatedWork W2111447213 @default.
- W2912781878 hasRelatedWork W2382568736 @default.
- W2912781878 hasRelatedWork W2969227266 @default.
- W2912781878 hasRelatedWork W3163448738 @default.